519 related articles for article (PubMed ID: 18365820)
1. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography.
Fishman EK; Reddan D
Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820
[TBL] [Abstract][Full Text] [Related]
2. Radiologists' knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists.
Reddan D; Fishman EK
Eur J Radiol; 2008 May; 66(2):235-45. PubMed ID: 17728089
[TBL] [Abstract][Full Text] [Related]
3. Recent issues in contrast-induced nephropathy.
Kitajima K; Maeda T; Watanabe S; Sugimura K
Int J Urol; 2011 Oct; 18(10):686-90. PubMed ID: 21834851
[TBL] [Abstract][Full Text] [Related]
4. Contrast-induced nephropathy--prevention and risk reduction.
Lameire NH
Nephrol Dial Transplant; 2006 Jun; 21(6):i11-23. PubMed ID: 16723348
[TBL] [Abstract][Full Text] [Related]
5. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures.
Schweiger MJ; Chambers CE; Davidson CJ; Blankenship J; Bhalla NP; Block PC; Dervan JP; Gasperetti C; Gerber L; Kleiman NS; Krone RJ; Phillips WJ; Siegel RM; Uretsky BF; Laskey WK
Catheter Cardiovasc Interv; 2007 Jan; 69(1):135-40. PubMed ID: 17139671
[TBL] [Abstract][Full Text] [Related]
6. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
Solomon R; Dumouchel W
Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
[TBL] [Abstract][Full Text] [Related]
7. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial.
Ozcan EE; Guneri S; Akdeniz B; Akyildiz IZ; Senaslan O; Baris N; Aslan O; Badak O
Am Heart J; 2007 Sep; 154(3):539-44. PubMed ID: 17719303
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].
Hoshino A; Enomoto S; Kawahito H; Kurata H; Nakahara Y; Nakamura T
J Cardiol; 2007 Aug; 50(2):119-26. PubMed ID: 17802695
[TBL] [Abstract][Full Text] [Related]
9. How to avoid CIN: guidelines from the European Society of Urogenital Radiology.
Thomsen HS
Nephrol Dial Transplant; 2005 Feb; 20 Suppl 1():i18-22. PubMed ID: 15705944
[TBL] [Abstract][Full Text] [Related]
10. Prevention of iodinated contrast-induced nephropathy.
Li JH; He NS
Chin Med J (Engl); 2011 Dec; 124(23):4079-82. PubMed ID: 22340345
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention.
McCullough P
Catheter Cardiovasc Interv; 2006 Mar; 67(3):335-43. PubMed ID: 16489569
[TBL] [Abstract][Full Text] [Related]
12. Contrast-induced nephropathy: the wheel has turned 360 degrees.
Thomsen HS; Morcos SK; Barrett BJ
Acta Radiol; 2008 Jul; 49(6):646-57. PubMed ID: 18568557
[TBL] [Abstract][Full Text] [Related]
13. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
Maioli M; Toso A; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Bellandi F
J Am Coll Cardiol; 2008 Aug; 52(8):599-604. PubMed ID: 18702961
[TBL] [Abstract][Full Text] [Related]
14. Contrast medium-induced nephropathy: strategies for prevention.
Massicotte A
Pharmacotherapy; 2008 Sep; 28(9):1140-50. PubMed ID: 18752385
[TBL] [Abstract][Full Text] [Related]
15. IV contrast administration for CT: a survey of practices for the screening and prevention of contrast nephropathy.
Elicker BM; Cypel YS; Weinreb JC
AJR Am J Roentgenol; 2006 Jun; 186(6):1651-8. PubMed ID: 16714655
[TBL] [Abstract][Full Text] [Related]
16. Contrast-induced nephropathy: are there differences between low osmolar and iso-osmolar iodinated contrast media?
Morcos SK
Clin Radiol; 2009 May; 64(5):468-72. PubMed ID: 19348841
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and therapy strategies for contrast-induced nephropathy.
Toprak O; Cirit M
Ren Fail; 2006; 28(5):365-81. PubMed ID: 16825085
[TBL] [Abstract][Full Text] [Related]
18. The value of hydration and acetylcysteine in the prevention of contrast-induced nephropathy: a potentially catastrophic complication of the percutaneous coronary interventions.
Iyisoy A; Celik T; Yuksel UC; Bugan B; Isik E
Int J Cardiol; 2009 May; 134(3):431-3; author reply 434. PubMed ID: 18501445
[TBL] [Abstract][Full Text] [Related]
19. Contrast medium use.
Davidson C; Stacul F; McCullough PA; Tumlin J; Adam A; Lameire N; Becker CR;
Am J Cardiol; 2006 Sep; 98(6A):42K-58K. PubMed ID: 16949380
[TBL] [Abstract][Full Text] [Related]
20. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.
Ferrario F; Barone MT; Landoni G; Genderini A; Heidemperger M; Trezzi M; Piccaluga E; Danna P; Scorza D
Nephrol Dial Transplant; 2009 Oct; 24(10):3103-7. PubMed ID: 19549691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]